Is folate or folic acid better for pregnancy
Searched over 200M research papers
Research Analysis by Consensus
Beta · 20 papersConsensus Meter
Yes%
Possibly%
No%
Folate vs. Folic Acid for Pregnancy: Which is Better?
Introduction to Folate and Folic Acid in Pregnancy
Folate (vitamin B9) and its synthetic counterpart, folic acid, are crucial for fetal development during pregnancy. Both forms are essential for DNA synthesis, repair, and methylation, which are vital processes for cell division and growth. However, there is ongoing debate about whether folate or folic acid is more beneficial for pregnant women.
Folate and Folic Acid: Mechanisms and Metabolism
Folic acid, the synthetic form of folate, must be converted by the liver into the active form, 5-methyltetrahydrofolate (5-MTHF), to be utilized by the body. This conversion process can be inefficient in some individuals due to genetic polymorphisms in the MTHFR gene, which can impair folate activation. In contrast, 5-MTHF is the bioactive form of folate and does not require conversion, making it immediately available for use in the body.
Efficacy in Maintaining Maternal Folate Status
Research indicates that both folic acid and 5-MTHF are effective in maintaining maternal folate status during pregnancy. A study comparing the two found no significant difference in erythrocyte and serum folate levels between groups supplemented with folic acid or 5-MTHF. However, the study noted that 5-MTHF supplementation resulted in lower levels of unmetabolized folic acid (UMFA) in the plasma, which could be beneficial as high UMFA levels have uncertain biological relevance.
Prevention of Neural Tube Defects and Other Congenital Anomalies
Folic acid supplementation is well-documented for its role in preventing neural tube defects (NTDs) and other congenital anomalies. Studies have shown that periconceptional use of folic acid significantly reduces the risk of NTDs . This protective effect is also observed with 5-MTHF, suggesting that both forms are effective in this regard.
Impact on Pregnancy Outcomes
While folic acid supplementation has been shown to improve certain pregnancy outcomes, such as increasing mean birthweight and reducing the incidence of megaloblastic anemia, it does not significantly impact other outcomes like preterm birth or stillbirths. Continued supplementation with folic acid beyond the first trimester can maintain maternal and cord blood folate levels and prevent increases in homocysteine, a marker associated with adverse pregnancy outcomes.
Considerations for High-Risk Populations
For women with genetic polymorphisms affecting folate metabolism or those at high risk for NTDs, 5-MTHF may offer advantages over folic acid. Since 5-MTHF does not require conversion, it can be more effective in individuals with impaired folate metabolism. Additionally, 5-MTHF supplementation avoids the accumulation of unmetabolized folic acid, which could pose potential health risks.
Conclusion
Both folic acid and 5-MTHF are effective in supporting maternal folate status and preventing neural tube defects during pregnancy. However, 5-MTHF may offer additional benefits for individuals with genetic polymorphisms affecting folate metabolism and in reducing plasma levels of unmetabolized folic acid. Further research is needed to fully understand the long-term implications of these differences on maternal and fetal health.
Sources and full results
Most relevant research papers on this topic